Geneart AG, of Regensburg, Germany, appointed Daniel Seibert chief financial officer.

Ikano Therapeutics Inc., of Saddlebrook, N.J., named Patrick Fabbio chief financial officer.

Integrated Genomics Inc., of Chicago, appointed Jose Laplaza director of strain engineering and lab operations.

Ipsen Group, of Paris, named Jean-Christophe Tellier president and general manager of the firm's North American operations.

Izumi Bio Inc., of South San Francisco, appointed Berta Strulovici chief technology officer and Dushyant Pathak vice president of business development. It also named Corey S. Goodman to its board.

Leerink Swann, of Boston, named Brent Clough senior managing director and head of MEDACorp.

Lexicon Pharmaceuticals Inc., of The Woodlands, Texas, appointed Ajay Bansal executive vice president of corporate development and chief financial officer.

Logical Therapeutics Inc., of Waltham, Mass., appointed Peter A. Lankau CEO.

MDRNA Inc., of Bothell, Wash., appointed Beverly L. Davidson and Carl Novina to its scientific advisory board.

MediGene AG, of Martinsried, Germany, appointed Frank Mathias CEO.

Mimetogen Pharmaceuticals Inc., of Montreal, appointed Martin B. Wax to its board.

Momenta Pharmaceuticals Inc., of Cambridge, Mass., appointed Bruce L. Downey to its board.

Nabriva Therapeutics, of Vienna, Austria, named George H. Talbot to its supervisory board.

NanoLogix Inc., of Hubbard, Ohio, named Sergey V. Gazenko, Brian Caplin, T. Dorai, Sushil Duddempudi, Deepak Kumar Mendiratta, P. Narang, Ravinder Narang, Cliff Watts and Chris Novak to its scientific advisory board chaired by Robert Ollar.

Nektar Therapeutics, of San Carlos, Calif., promoted Lorianne Masuoka to chief medical officer.

Orexigen Therapeutics Inc., of San Diego, named Jay Hagan senior vice president of corporate development and strategy.

Par Pharmaceutical Cos. Inc., of Woodcliff Lake, N.J., elected Thomas P. Rice to its board.

Pozen Inc., of Chapel Hill, N.C., elected Angela M. Larson to its board.

Protein Sciences Corp., of Meriden, Conn., named Howard L. Levine to its board.

PTC Therapeutics Inc., of South Plainfield, N.J., appointed Clare Kennedy vice president of commercial operations.

Qteros, of Marlborough, Mass., named Anthony J. "Tony" Tether to its board.